Recently, the Haidian District Market Supervision Administration of Beijing reviewed and announced the 2024 Haidian District SME High-Value Patent Cultivation and Layout Special Support Program, the 2024 Haidian District SME Patent Award Supporting Program, and the 2024 Haidian District Intellectual Property Securitization Financing Cost Subsidy Program. After relevant procedures, the final support list was formed. METiS Technologies has been granted support under the “2024 Haidian District SME High-Value Patent Cultivation and Layout Special Program.”
To date, METiS Technologies has filed more than 130 patent applications and obtained over 30 granted patents, covering AI-driven drug delivery systems, AI-assisted complex formulation optimization, and AI-powered nucleic acid drug development, across therapeutic areas including oncology, obesity, degenerative diseases, and autoimmune disorders. In addition, the company holds multiple software copyrights and registered trademarks, continuously building a broad and deep intellectual property moat.
This special support represents high recognition of METiS Technologies’ capabilities in independent innovation and patent value transformation. It will further accelerate the company’s technology implementation and promote the clinical translation of more high-value outcomes.
